In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Simvastatin with niaspan improves neurological outcome after experimental intracerebral hemorrhage

    Final Number:
    319

    Authors:
    Dongmei Yang; Yuxia Han BS; Jianfeng Zhang; Michael Chopp PhD; Donald M. Seyfried MD

    Study Design:
    Laboratory Investigation

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2012 Annual Meeting

    Introduction: This study will measure the impact of combination treatment of simvastatin, a cholesterol-lowering drug, and niaspan, a prolonged-release formulation of vitamin B3, on functional outcome, cell proliferation and vascularity after experimental intracerebral hemorrhage (ICH).

    Methods: Primary ICH was induced in 32 male Wistar rats by stereotactic injection of 100 ?L of autologous blood into the striatum. Rats were divided into four groups (n= 8/group): 1) simvastatin 2 mg/kg, 2) niaspan 40 mg/kg, 3) combination, and 4) phosphate buffered saline (PBS) daily starting 24-hours post-ICH and continuing daily for 7 days. To evaluate the neurological functional outcome, each animal was subjected to the modified neurological severity score (mNSS) and corner turn tests at different time points after ICH. At 14 days post treatment, each group was anesthetized, sacrificed, and the brain tissues were processed histologically. Immunohistochemistry was employed to measure vascularity (BrdU and vWF) and neurogenesis (BrdU and DCX).

    Results: The animals treated with simvastatin alone, niaspan alone and combination-therapy showed significantly improved neurological functional outcomes as assessed by mNSS and corner turn tests at 14 days post-injection (p<0.05) as compared to PBS controls. The animals in each treatment group were seen to have significantly increased cell proliferation and vascularity, compared to the corresponding control group (p<0.05).

    Conclusions: Our data suggest that treatment of experimental ICH with simvastatin and niaspan has a beneficial effect as demonstrated by the functional and histochemical measurements of neurogenesis and angiogenesis.

    Patient Care: This study and others like it add to our body of knowledge regarding post ICH treatment and care. Eventually this will lead to more effective therapies and improved functional outcome for patients suffering from intracerebral hemorrhage.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) describe the therapeutic effect of simvastatin and/or niaspan in intracranial hemorrhage (ICH), 2) identify the cell proliferation after ICH in the adult rat, and 3) identify increased vascularity after ICH in the adult rat.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy